Epithelioid Sarcoma

Summary
Description

Epithelioid sarcoma (ES) is an aggressive mesenchymal neoplasm with a poor prognosis. Based on clinical and histological features, the tumor is divided into proximal and distal subtypes. Both subtypes are characterized by the loss of SMARCB1 expression. The tumor is frequently misdiagnosed. The principal distal sites are the fingers, hands, and forearms. Prompt diagnosis followed by aggressive surgical resection with wide or radical margins is the most effective treatment.

People and Age
The tumor has two subtypes - proximal and distal. The distal subtype is most prevalent in adolescents and young adults between 10 and 35 years of age. Male patients outnumber females by about 2:1.
Symptoms and Presentation
The tumor nearly always presents as a slow growing mass. There may be minimal or no pain and no loss of function.
Brief description of the xray
The xrays show occasional speckled calcification, but may otherwise be unremarkable. Plain xrays are recommended to rule out other types of lesions and evaluate any possible bone involvement.
Brief desc of tx
Adequate treatment for this very aggressive and difficult tumor requires early recognition of the true nature of the tumor, followed by complete assessment of the entire extremity and lungs to assess the full extent of the tumor. Surgical treatment requires early radical excision or amputation if the primary tumor is situated in the fingers or toes. Treatment options for tumors which have metastasized are much more limited. Limb salvage may be possible in selected cases.
Tumor Name
Benign or Malignant
Most Common Bones
Tumor behavior
Tumor density
Complete Information on this Tumor
Introduction and Definition

Epithelioid sarcoma (ES) is an aggressive mesenchymal neoplasm with a poor prognosis. Based on clinical and histological features, the tumor is divided into proximal and distal subtypes. The benign, cutaneous clinical presentation leads to a high risk of misdiagnosis and delay. Although this sarcoma is generally rare, the most common location for the distal subtype is the distal upper and lower extremities, with approximately 15% of all cases located in the distal lower extremity. The tumor grows and spreads along lymph and vascular channels as well as tendon sheaths leading to more generalized swelling and a permeative mass. The most common sites are the fingers, hands, and forearms. The tumor spreads to lymph nodes, proximal soft tissue sites, and to the lung. Epithelioid sarcoma is the most common soft tissue sarcoma in the hand and wrist, followed by alveolar rhabdomyosarcoma and synovial sarcoma.

Incidence and Demographics
The proximal subtype is an aggressive variant, which occurs in the soft tissues of the proximal part of the extremities, such as the pelvis, groin, perineum, genitals, axilla, head and neck, and other areas. The proximal subtype is somewhat more common in males, and patients are typically young - average age is around 35 years. There are histological differences noted in the histology section elow. The proximal subtype appears to me more aggressive and may metastasize at an earlier stage. The distal subtype occurs in predominanatly in the forearm, hand, wrist, and fingers. The tumor is most prevalent in adolescents and young adults between 10 and 35 years of age. Male patients outnumber females by about 2:1. Due to the innocent appearance of the lesion, the average time from presentation to the correct diagnosis is around 18 months.
Symptoms and Presentation

The tumor may present as a small, firm superficial or deep nodule or a focal cluster of nodules. Regional multifocal presentation is an unusual characteristic displayed by this tumor. This tumor is frequently misdiagnosed as a skin condition, warts, or corns, and a correct diagnosis may be delayed with serious medical and legal consequences. About one half of the tumors are not painful. The tumor occurs in both subcutis and deeper tissues. When located in the subcutis, it usually presents as a firm nodule that may be solitary or multiple, has a calluslike consistency, and is often described as a “woody hard knot” or :firm lump” that is slow growing and painless. Nodules situated in the dermis are often elevated above the skin surface and frequently become ulcerated weeks or months after they are first noted. Such lesions are often erroneously diagnosed as an “indurated ulcer”, “draining abscess”, or “infected wart” that fails to heal despite intensive therapy. The majority of tumors are 3 to 6 cm in diameter.

Lymph node metastasis should be evaluated at the time of presentation, due to the unusual propensity of this tumor to spread to regional nodes. In general, lymph node metastasis in sarcomas are quite rare, occurring in about 2.6% of all sarcoma patients in large series. In ES, however, the rate of lymph node metastasis is around 30% (range 14 - 44%) Lung metastasis occurs in 20-40% of patients.

X-Ray Appearance and Advanced Imaging Findings
Roentgenogram reveals a soft tissue mass with an occasional speckled pattern of calcification, and with infrequent cortical thinning and erosion of underlying bone .
MRI Findings
MR may show intratumoral hemorrhage. The lesion does not have diagnostic MR features.
CT Findings
Occasional calcifications, but otherwise nonspecific.
Laboratory Findings
Both subtypes are characterized by the loss of SMARCB1 expression. This tumor suppressor gene encodes for a protein which is an interactor protein with HIV integrase. It is located on chromosome 22q11.2
Differential Diagnosis
The frequency with which the tumor is mistaken for a benign process is a result of its deceptively harmless appearance during the initial phase of the disease. Superficially located tumors of small size with a nodular or multinodular pattern are likely to be mistaken for an inflammatory process. Neoplasms arising from the tendons can be mistaken with synovial sarcoma. Distinction can be successfully accomplished if attention is paid to the persistent absence of a biphasic pattern, pseudoglandular structures and intracellular mucin, as well as the larger size and prominent eosinophilia of the tumor cells. Dermal involvement and ulceration are much more common with epithelioid sarcoma than with synovial sarcoma.
Histopathology findings
Gross inspection usually shows the presence of one or more nodules measuring 0.5 to 5 cm in diameter. The cut surface has a glistening gray-white or gray tan mottled surface with focal yellow or brown areas caused by focal necrosis or hemorrhage.
The principal microscopic characteristics are the distinct nodular arrangement of the tumor cells, their tendency to undergo central degeneration and necrosis, and their epithelioid appearance and eosinophilia. The nodular pattern, probably the most conspicuous single feature of epithelioid sarcoma, varies somewhat; in some tumors the nodules are well circumscribed; in others they are less well defined and are often compacted into irregular multinodular masses. Necrosis of the tumor nodules is a common finding; it is most prominent in the center of the nodules and at times is associated with hemorrhage and cystic change. When tumor spreads within a fascia or aponeurosis, it forms festoonlike or garlandlike bands punctuated by areas of necrosis.

The constituent cellular elements range from large ovoid or polygonal cells with deply eosinophilic cytoplasm, suggesting a rhabdomyosarcoma or malignant rhabdoid tumor, to plump spindle-shaped cells reminiscent of fibrosarcoma or malignant fibrous histiocytoma. In some of the latter tumors the spindle cell pattern may predominate and may obscure the characteristic epithelioid features and nodularity.
Cytogenetic analysis of an epithelioid sarcoma cell line revealed a karyotype of 64 to 66 chromosomes with extensive numerical and structural rearrangements and up to 24 marker chromosomes.

Immunohistochemical findings

The cells show coexpression for low-molecular-weight (45 kd and 54 kd) and high- molecular- weight (57 kd) cytokeratin, vimentin, and epithelial membrane antigen.

Ultrastructural findings

Most investigators report polygonal and spindle shaped cells with ovoid, indented nuclei having small amounts of marginally places chromatin. The cytoplasm contains arrays of rough endplasmic reticulum, a prominent Golgi apparatus, and free ribosomes as well as occasional mitochondria, lysosomes, and droplets of osmophilic material. Intermediate filaments are a common and striking feature. They may be arranged longitudinally as in myofibroblasts or more often from paranuclear masses or whorls, a feature that probably accounts for the voluminous cytoplasm and the striking epithelioid appearance and eosinophilia of the tumor cells.
Treatment Options for this Tumor
Adequate treatment for this very aggressive and difficult tumor requires early recognition of the true nature of the tumor, followed by complete assessment of the entire extremity and lungs to assess the full extent of the tumor. Regional lymph node dissection should be included among the therapeutic modalities because lymph node metastasis is a fairly common occurrence in epithelioid sarcoma.

Surgical treatment requires early radical excision or amputation if the primary tumor is situated in the fingers or toes. Treatment options for tumors which have metastasized are much more limited. Limb salvage may be possible in selected cases.

For surgically controllable disease, surgical removal with a very wide or radical margin is mandatory. Local and regional metastasis may necessitate amputation. hand and palm lesions are best treated with complete amputation. Amputation should also be considered as treatment for recurrent growth, but does not seem to offer any benefit to patients with distant metastasis.

In all cases surgical treatment should be combined with radiotherapy and multiagent chemotherapy over a prolonged period.
Preferred Margin for this Tumor
Radical
Outcomes of Treatment and Prognosis
The local recurrence rate is approximately 35% and the rate of distant metastasis is about 40%, with the regional lymph nodes and lungs being the most common metastatic sites. Metastasis to regional lymph nodes occurs in 25% of cases. Five and ten year survival is 70% and 42%. Prognosis depends on various factors, chiefly the sex of the patient, the depth of the tumor, the number of mitotic figures, and the presence or absence of hemorrhage, necrosis, and vascular invasion. Moreover, tumors in the distal extremities have a more favorable prognosis than those in the trunk and proximal portions of the limbs.
Special and Unusual Features
Adequate treatment of this tumor is a significant challenge for several reasons. First, he tumor is rare and may present as an innocent looking lesion in a varietly of cutaneous locations. The lesion may be treated by dermatologists, plastic surgeons, general surgeons, obstetrician gynecologists, general medical doctors and others who do not normally encounter sarcomas, much less this rare sarcoma.

Second, the lesion affects the hand and wrist in a large proportion of cases, and the initial surgical management may be performed by a hand specialist. Hand and wrist surgeons may feel obligated to preserve sensation and function, rather than to radically resect tumors and nearby structures that may be essential, such as bone, nerve, and tendon. This may lead to inadequate initial surgical margins. Inadequate surgical margins are known to increases the risk of local recurrence and tumor metastasis. In general, many surgeons are reluctant to perform the radical procedures required to control this tumor, and local recurrence and regional or systemic metastasis may occur.

The potential of the tumor to recur and metastasize is clearly evident. Most common sites of sites are lymph nodes and the skin, and the scalp. Multiple recurrences, often a result of marginal resection are a characteristic feature of the tumor. The recurrent tumor generally presents as confluent nodules in the dermis or along tendons and fascial structures at or near the original tumor site. Recurrence generally develops within first year after diagnosis, but may be late. Metastases may manifest before detection of the primary tumor.